Search for: "In Re: Blue Cross Blue Shield Antitrust Litigation"
Results 1 - 18
of 18
Sorted by Relevance
|
Sort by Date
30 Oct 2023, 10:20 am
McConnell Duane Morris Takeaways: On October 25, 2023, in the litigation of In Re Blue Cross Blue Shield Antitrust Litigation, MDL No. 2406 (11th Cir. [read post]
17 Dec 2018, 5:26 am
The case is In re Blue Cross Blue Shield Antitrust Litigation, Case No. 13-cv-2000, MDL 246 (N.D. [read post]
17 Dec 2018, 5:26 am
The case is In re Blue Cross Blue Shield Antitrust Litigation, Case No. 13-cv-2000, MDL 246 (N.D. [read post]
2 Sep 2022, 3:59 pm
register and attend the September 8, 2022 Justice Department Health Industry Antitrust Enforcement Update to learn about key federal antitrust statutes regulating or prohibiting anticompetitive conduct and business transactions, how the Department of Justice uses these laws to promote market competition in the health care and health insurance marketplaces and update on recent $2.67 billion settlement of the In re: Blue Cross Blue Shield… [read post]
31 Oct 2022, 4:47 pm
The November 1, 2022 American Bar Association Tort Trial & Insurance Section Medicine & Law Committee November Learning Session will focus on the details and likely implications of the groundbreaking August 8, 2022 settlement of the long-running In Re Blue Cross And Blue Shield Litigation on the commercial health insurance market and the health care provider contracting, payment and other relations by Blue Cross… [read post]
31 Oct 2022, 4:55 pm
The November 1, 2022 American Bar Association Tort Trial & Insurance Section Medicine & Law Committee November Learning Session will focus on the details and likely implications of the groundbreaking August 8, 2022 settlement of the long-running In Re Blue Cross And Blue Shield Litigation on the commercial health insurance market and the health care […] [read post]
2 Sep 2022, 4:33 pm
Attorney and Solutions Law Press, Inc. editor and author Cynthia Marcotte Stamer also will provide an update on the In re: Blue Cross Blue Shield Antitrust Litigation and resulting $2.67 billion settlement approved August 9. [read post]
26 Apr 2021, 2:13 pm
We are also involved in an antitrust case, alleging price fixing and allocation of territories against numerous Blue Shield and Blue Cross entities that is pending in Alabama, and is considered one of the largest antitrust cases ever filed. [read post]
1 Sep 2020, 10:26 am
Anthem allegedly failed to try to change rules stemming from its relationship with the Blue Cross Blue Shield Association, primarily the Association’s requirement that it use best efforts to generate at least two-thirds of its total revenue using the Blues brands.The chancery court reasoned that the parties entered the merger agreement knowing that the so-called Blues Rules were unlikely to change and that the best avenue for change was… [read post]
17 Nov 2023, 6:41 am
In re Blue Cross Blue Shield Antitrust Litig. [read post]
23 Jan 2011, 10:44 pm
In Blue Cross and Blue Shield of Mass. v. [read post]
5 Apr 2017, 3:01 am
So I moved into litigation, which was much better suited to my skills and temperament. [read post]
27 Aug 2011, 4:34 am
The dismissal was based on the grounds that some of the claims of named plaintiffs were moot and that the remaining named plaintiffs had failed to exhaust available remedies as required by the Prison Litigation Reform Act of 1995 (PLRA), 42 U.S.C. 1997e. [read post]
15 Jul 2019, 5:01 am
Horizon Blue Cross Blue Shield of N.J., 663 F.3d 1124, 1135 (10th Cir. 2011). [read post]
4 Jun 2018, 3:04 pm
Horizon Blue Cross Blue Shield of N.J., 663 F.3d 1124, 1135 (10th Cir. 2011). [read post]
19 Feb 2016, 11:57 am
Corporation with no in-state assets, employees, or registered agent, cannot be at home.In re Roman Catholic Diocese of Albany, New York, Inc., 745 F.3d 30 (2d Cir. [read post]
10 Apr 2012, 7:47 am
We can debate the normative or ethical considerations until we’re all blue in the face and ready to rip each other’s heads off, but I am less and less interested in such squabbles. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
